← All diseases
Cancer
Childhood cancer: neuroblastoma and DIPG
Would you like to receive a message when there is new research about Childhood Cancer: neuroblastoma and DIPG? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you'll find one sentence explaining what was studied — and you'll receive a notification as soon as new research is available on Childhood cancer: neuroblastoma and DIPG. View what Premium costs.
Publications and studies (2128)
- Humanin Treatment Protects Against Venetoclax-Induced Bone Growth Retardation in Ex Vivo Cultured Rat Bones. (2024/01/25) ♡
- A peptide encoded by the circular form of the SHPRH gene induces apoptosis in neuroblastoma cells. (2024/01/23) ♡
- Divergent HLA variations and heterogeneous expression but recurrent HLA loss-of- heterozygosity and common HLA-B and TAP transcriptional silencing across advanced pediatric solid cancers. (2024/01/22) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Asymmetric Adrenals: Sexual Dimorphism of Adrenal Tumors. (2024/01/18) ♡
- Neuroprotective Effect of Solid Lipid Nanoparticles Loaded with Lepidium sativum (L.) Seed Bioactive Components Enhance Bioavailability and Wnt/β-Catenin/Camk-II Signaling Cascade in SH-SY5Y Neuroblastoma Cells. (2024/01/16) ♡
- Aggregation of E121K mutant D-amino acid oxidase and ubiquitination-mediated autophagy mechanisms leading to amyotrophic lateral sclerosis. (2024/01/15) ♡
- Microfluidic model of the alternative vasculature in neuroblastoma. (2024/01/15) ♡
- Huannao Yicong decoction ameliorates cognitive deficits in APP/PS1/tau triple transgenic mice by interfering with neurotoxic interaction of Aβ-tau. (2024/01/10) ♡
- ALK F1174S mutation impairs ALK kinase activity in EML4-ALK variant 1 and sensitizes EML4-ALK variant 3 to crizotinib. (2024/01/09) ♡
- Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapy. (2024/01/08) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. GD2-CAR CAR T cells in patients with osteosarcoma and neuroblastoma-it's not only the T cells that matter. (2024/01/08) ♡
- Current vaccination status and safety of children with peripheral neuroblastoma in the real-world. (2024/01/08) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case report: A safeguard in the sea of variants of uncertain significance: a case study on child with high risk neuroblastoma and acute myeloid leukemia. (2024/01/08) ♡
- Reprogramming neuroblastoma by diet-enhanced polyamine depletion. (2024/01/08) ♡
- Metabolomics-transcriptomics joint analysis: unveiling the dysregulated cell death network and developing a diagnostic model for high-grade neuroblastoma. (2024/01/04) ♡
- ChemR23 signaling ameliorates brain injury via inhibiting NLRP3 inflammasome-mediated neuronal pyroptosis in ischemic stroke. (2024/01/04) ♡
- ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition. (2024/01/02) ♡
- Neuroprotective role of FOXA1 in Parkinson's disease: Involvements of NF1 transcription activation and MAPK signaling pathway inhibition. (2024/01/01) ♡
- Pathologic changes in neuronal intranuclear inclusion disease are linked to aberrant FUS interaction under hyperosmotic stress. (2024/01/01) ♡
- The role of insulinoma-associated protein 1 in predicting the progression and prognosis of human olfactory neuroblastoma in China. (2024/01/01) ♡
- Pimecrolimus protects neuron-like SH-SY5Y cells against anti-inflammatory and anti-oxidant effects of both microglial secretome and hydrogen peroxide. (2024/01/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Cytotoxic effect of Rotheca serrata on cancer cell lines MCF-7 and neuroblastoma SH-SY5Y. (2024/01/01) ♡
- Clinical and histopathological spectrum of cranial small round cell tumors: An experience from a tertiary care center. (2024/01/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Effects of astaxanthin on expression of apoptosis and oxidative stress related genes in H(2)O(2) induced oxidative stress BE(2)-C human neuroblastoma cell line. (2024/01/01) ♡
- Comments on 'neuroblastoma in Sudan: experience of a single institute'. (2024/01/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Impact of ovarian insufficiency on bone health in childhood cancer survivors: Two cases. (2024/01/01) ♡
- Effects of cylindrospermopsin, chlorpyrifos and their combination in a SH-SY5Y cell model concerning developmental neurotoxicity. (2024/01/01) ♡
- Nutritional status associated with clinical outcomes in children with solid tumors: A retrospective cohort study from China. (2024/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Improving susceptibility of neuroendocrine tumors to radionuclide therapies: personalized approaches towards complementary treatments. (2024/01/01) ♡
- Effectiveness of Nutrition Support Team Intervention in Pediatric Patients with Cancer. (2024/01/01) ♡
- Preoperative visualization of the Adamkiewicz artery in infant neuroblastoma. (2024/01/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Paraneoplastic opsoclonus-myoclonus syndrome]. (2024/01/01) ♡
- The Involvement of the NEAT1-1/miR-873-5p/GalNAcT-I Axis in the Development of Neuroblastoma. (2024/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Preliminary Activity of Idasanutlin in Combination With Either Chemotherapy or Venetoclax in Treatment of Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias or Solid Tumors (2024-12-20) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Study on the Efficacy of GD2-CAR T Cells in the Treatment of Neuroblastoma (2024-12-20) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial) (2024-12-11) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. 131I-Metaiodobenzylguanidine (131I-MIBG) Therapy for Relapsed/Refractory Neuroblastoma (2024-12-11) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Chemotherapy in Treating Children With Neuroblastoma (2024-11-20) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. 18F-mFBG LAFOV PET/CT Compared to 123I-mIBG Scintigraphy SPECT/CT for Evaluation of Children With Neuroblastoma (2024-11-15) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products (2024-10-30) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Nab-paclitaxel in Combination with Gemcitabine for Pediatric Relapsed and Refractory Solid Tumors (2024-10-04) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Evaluation of the Safety and Pharmacokinetics of Dinutuximab Beta As Maintenance Therapy in Chinese Participants With High-Risk Neuroblastoma (2024-10-04) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer (2024-10-02) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Real World Data Collection Pediatric Neuroblastoma Treated With Lorlatinib (2024-09-23) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Study Of Naxitamab , Granulocyte Macrophage Colony Stimulating Factor For Patients With Relapsed /Refractory , Soft Tissue or Anti GD2 Immunotherapy Refractory Neuroblastoma (2024-08-29) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Adding Of Naxitamb In Induction Therapy For High Risk Neuroblastoma (2024-08-28) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. International Congenital Central Hypoventilation Syndrome (CCHS) Registry and CCHS SHARE (2024-08-09) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Neurocognition in Congenital Central Hypoventilation Syndrome (CCHS) (2024-08-09) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy for Neuroblastoma (2024-08-07) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide (2024-08-06) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.